A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: results of a 20 year audit
References (37)
- et al.
Malignant mesothelioma
Lancet
(2005) - et al.
The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma
Chest
(1997) - et al.
Malignant pleural mesothelioma: ESMO clinical recommendations for diagnosis, treatment and follow-up
Ann Oncol
(2008) - et al.
Prophylactic radiotherapy to intervention sites in mesothelioma: a systematic review and survey of UK practice
Lung Cancer
(2009) Asbestos and mesothelioma: worldwide trends
Lung Cancer
(2005)Fine needle aspiration or core biopsy
Breast
(1999)- et al.
Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity
Mod Pathol
(2006) What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update
Hum Pathol
(2007)- et al.
Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma
Ann Thorac Surg
(2004) - et al.
Advances in malignant mesothelioma
N Engl J Med
(2005)
The separation of benign and malignant mesothelial proliferations
Am J Surg Pathol
(2000)
Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group
Arch Pathol Lab Med
(2009)
Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: Diagnosis
Cancer
(1993)
The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesothelioma
Histopathology
(2008)
Prophylactic radiotherapy for pleural puncture sites in mesothelioma: the controversy continues
Curr Opin Pulm Med
(2008)
Malignant mesothelioma in Australia, 1945–2002
Int J Occup Environ Health
(2003)
The cytology of malignant mesothelioma
Cytopathology
(2000)
College of American Pathologists Committee on Nomenclature and Classification of Disease
Cited by (106)
The cytologic diagnosis of mesothelioma: are we there yet?
2023, Journal of the American Society of CytopathologyMalignant and borderline mesothelial tumors of the pleura
2022, Practical Pulmonary Pathology: A Diagnostic ApproachMalignant Pleural Mesothelioma: Updates for Respiratory Physicians
2021, Clinics in Chest MedicineMedical Thoracoscopy
2021, Clinics in Chest MedicineCitation Excerpt :The diagnosis is generally considered difficult if not impossible to make by PFA-derived cytology; pleural biopsies are usually required. Sensitivity for MPM via PFA varies widely.4,53 Data suggest that pleural fluid cytology has poor sensitivity for diagnosing MPM (20%–51%).12,54,55
The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis
2021, PathologyCitation Excerpt :Many patients present with recurrent pleural effusions, and there is the possibility of diagnosis of MM with an epithelioid component by cytology in isolation, which is embraced by some groups but regarded more cautiously or rejected by others.4,6–8 However, there are ample data to indicate that in skilled hands, cytological diagnosis of MM is reliable.9,10 In addition to these difficulties, benign asbestos related effusions are recognised.
Pleural Effusions: Overview and Diagnostic Approach
2021, Encyclopedia of Respiratory Medicine, Second Edition
Copyright © 2013 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.